Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
about
Developmental coronary maturation is disturbed by aberrant cardiac vascular endothelial growth factor expression and Notch signallingTherapeutic angiogenesis: controlled delivery of angiogenic factors.Regenerative therapies for diabetic microangiopathyEpigenetic upregulation of endogenous VEGF-A reduces myocardial infarct size in miceStem Cell Therapy for the Heart: Blind Alley or Magic Bullet?Identification of a potent endothelium-derived angiogenic factorSystems biology of pro-angiogenic therapies targeting the VEGF systemVEGF and soluble VEGF receptor-1 (sFlt-1) distributions in peripheral arterial disease: an in silico model.Multiscale models of angiogenesisA systems biology perspective on sVEGFR1: its biological function, pathogenic role and therapeutic use.Computational kinetic model of VEGF trapping by soluble VEGF receptor-1: effects of transendothelial and lymphatic macromolecular transport.Systems biology of vascular endothelial growth factorsA compartment model of VEGF distribution in humans in the presence of soluble VEGF receptor-1 acting as a ligand trapPerspectives and opportunities for nanomedicine in the management of atherosclerosis.Controlled angiogenesis in the heart by cell-based expression of specific vascular endothelial growth factor levels.High Plasma Lipid Levels Reduce Efficacy of Adenovirus-Mediated Gene TherapyRelationships of growth factors, proinflammatory cytokines, and anti-inflammatory cytokines with long-term clinical results of autologous bone marrow mononuclear cell transplantation in STEMICirculating angiopoietins-1 and -2, angiopoietin receptor Tie-2 and vascular endothelial growth factor-A as biomarkers of acute myocardial infarction: a prospective nested case-control studyCoupling growth-factor engineering with nanotechnology for therapeutic angiogenesis.Practical Management Recommendations for Anti-ErbB2 Therapy with Lapatinib.A titratable two-step transcriptional amplification strategy for targeted gene therapy based on ligand-induced intramolecular folding of a mutant human estrogen receptorSupramolecular nanostructures that mimic VEGF as a strategy for ischemic tissue repairMicroRNA-377 regulates mesenchymal stem cell-induced angiogenesis in ischemic hearts by targeting VEGFCeramide-activated phosphatase mediates fatty acid-induced endothelial VEGF resistance and impaired angiogenesisFlk-1/KDR mediates ethanol-stimulated endothelial cell Notch signaling and angiogenic activityComprehensive Proteomic Analysis of Mesenchymal Stem Cell Exosomes Reveals Modulation of Angiogenesis via Nuclear Factor-KappaB Signaling.Dysfunction of circulating endothelial progenitor cells in type 1 diabetic rats with diabetic retinopathy.Early vessel destabilization mediated by Angiopoietin-2 and subsequent vessel maturation via Angiopoietin-1 induce functional neovasculature after ischemia.Transplantation of microencapsulated genetically modified xenogeneic cells augments angiogenesis and improves heart function.Hypoxia and fetal heart development.Eight-year safety follow-up of coronary artery disease patients after local intracoronary VEGF gene transfer.The effects of VEGF-R1 and VEGF-R2 ligands on angiogenic responses and left ventricular function in mice.Update on gene therapy for myocardial ischaemia and left ventricular systolic dysfunction or heart failure.Angiomyeloproliferative lesions following autologous stem cell therapy.Age related vascular endothelial function following lifelong sedentariness: positive impact of cardiovascular conditioning without further improvement following low frequency high intensity interval training.Genome-wide association study for endothelial growth factorsTherapeutic manipulation of angiogenesis with miR-27bGeneration of human adult mesenchymal stromal/stem cells expressing defined xenogenic vascular endothelial growth factor levels by optimized transduction and flow cytometry purificationRelation of vascular growth factors with CT-derived measures of body fat distribution: the Framingham Heart Study.Significance of vascular endothelial growth factor in growth and peritoneal dissemination of ovarian cancer.
P2860
Q24304298-140969F6-3556-4AF9-BD9E-9880E6E1947BQ27023731-0532251A-B4DE-444F-9B11-9ECBAC68ACB7Q27027852-64699F27-21FF-49A0-B2BD-E55A48E96397Q27319477-6D6D5B08-27DD-4E57-AC2C-5C040E4579FDQ28069300-AE466BC3-D246-403A-B263-FA18CCC3ACB8Q28534947-6C887BD7-63E8-4514-8CA6-DF7F9829AE0BQ30430112-13B9E6E5-00CA-4647-8625-7AEE2746B1AEQ30432040-F8C3669A-2AD5-4447-B26C-41A333F7A0EBQ30432668-0F520158-63CC-406B-BC89-0A792CC3DA33Q30433214-E91FB9C4-6863-4528-A569-800BEB8943B0Q30436024-82AF0A1F-BE02-479D-A34F-0714EBD83F84Q30438979-A573DD02-AAE0-4333-8450-412DBE6419DDQ30439884-B28AF814-89B0-4922-95F7-EAE52EACD77EQ30455490-76A69AEB-CAE4-4D2A-B300-278843ADDA9CQ33586957-FC18890A-8F23-43C8-A06F-E77EC9405B40Q33670765-25C99731-1396-4BCC-8AF9-50669DB2F9C9Q33739109-F2453166-E695-419A-8FFC-2A9DF909BD3FQ33932129-2F5AA0B3-FB60-4663-92C2-D223CE939AA8Q34068511-624609EF-A168-42A0-AE5B-5C072BABD5EFQ34095753-F8712640-94CA-47E3-8B91-5943F5982016Q34134386-A1B69147-BF57-4EFD-AC54-52EB4336F872Q34205393-8A127657-5BEB-4B84-B83A-54AF0041B6BAQ34241026-C1C1A493-55CC-476B-BA22-80C93E21291EQ34408930-572E8EAA-6B3B-48B1-AA4C-1346CED99E58Q34437702-CD01085A-D2F9-4548-B6F8-9573AC7E4674Q34509669-457EE806-01D6-46F8-91D2-AD0EFFCCC397Q34577875-DD8FD59A-698B-44DF-9964-1D164F7796D0Q34685212-030FA377-BB20-4233-B412-D21BE22D201CQ34702508-9C673FE6-A045-4EA3-B56B-DABCED189110Q34788585-BB2C7583-22DF-4E44-A614-5A4B3D63B24DQ34943604-B20234FD-27BF-4ED5-A424-8054827FE728Q35015659-7F6E56C9-3657-4992-B711-11FB3A0645F0Q35069886-428E0D59-94AA-4D02-9262-AC3A8527CCBDQ35153218-52C62EEC-4FFD-4EA3-A464-F996AC85C7FDQ35294370-6F42E343-A79E-445B-A068-F42C8630DC2FQ35528233-6E2A73A9-A6EA-4C7D-AE75-3574093B72A0Q35835060-2DDD6B34-49CF-48EC-BEB6-9E447916D8DDQ35851399-E87D2296-68D1-4E78-B5D3-004E6A5E051AQ35869624-36831CA7-6E0D-49FD-B923-23AB247E88D0Q35954103-4C07DBFF-6BD9-4686-B1AD-2E6165E056DC
P2860
Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@ast
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@en
type
label
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@ast
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@en
prefLabel
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@ast
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@en
P2093
P1476
Vascular endothelial growth fa ...... ns in cardiovascular medicine.
@en
P2093
Ismo Vajanto
Juha Hartikainen
Tuomas T Rissanen
P304
P356
10.1016/J.JACC.2006.09.053
P407
P577
2007-02-23T00:00:00Z